angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, ZJ; Elias, PD; Harding, JW; Hudson, BD; Masino, JA; McCoy, AT; Sardinia, MF; Varnum, MD; Wright, JW; Yamamoto, BJ | 1 |
| Harding, JW; Kawas, LH; McCoy, AT; Wright, JW; Yamamoto, BJ | 1 |
2 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and B16 Melanoma
| Article | Year |
|---|---|
The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor.
Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dogs; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hepatocyte Growth Factor; Humans; In Vitro Techniques; Lung; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Proto-Oncogene Proteins c-met; Radioligand Assay; Signal Transduction | 2010 |
Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers.
Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Dogs; Hepatocyte Growth Factor; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Protein Multimerization; Proto-Oncogene Proteins c-met; Rats; Rats, Sprague-Dawley; Signal Transduction | 2012 |